Efficacy and safety of nanosomal docetaxel lipid suspension based chemotherapy in gastric and gastroesophageal junction adenocarcinoma.

Subramanian, Sundaram; Majumdar, Saroj Kumar Das; Biswas, Ghanashyam; Joshi, Nisarg; Bunger, Deepak; Khan, Mujtaba Ali; Ahmad, Imran

Subramanian, Sundaram; Majumdar, Saroj Kumar Das; Biswas, Ghanashyam; Joshi, Nisarg; Bunger, Deepak; Khan, Mujtaba Ali; Ahmad, Imran.

Afiliación

Subramanian S; Department of Medical Oncology, VS Hospital, Madras Cancer Institute, Advanced Cancer Care, Chennai, Tamil Nadu 600031, India.
Majumdar SKD; Department of Radiotherapy, All India Institute of Medical Sciences, Bhubaneswar, Odisha 751019, India.
Biswas G; Department of Medical Oncology, Sparsh Hospital, Bhubaneswar, Odisha 751007, India.
Joshi N; Medical Affairs and Clinical Development, Intas Pharmaceuticals Ltd., Sola, Ahmedabad, Gujarat 380054, India.
Bunger D; Medical Affairs and Clinical Development, Intas Pharmaceuticals Ltd., Sola, Ahmedabad, Gujarat 380054, India.
Khan MA; Medical Affairs and Clinical Development, Intas Pharmaceuticals Ltd., Sola, Ahmedabad, Gujarat 380054, India.
Ahmad I; Jina Pharmaceuticals Inc., Libertyville, IL 60048, USA.

Mol Clin Oncol ; 13(3): 14, 2020 Sep.

Article en En | MEDLINE | ID: mdl-32754328

Palabras clave

NDLS; gastric adenocarcinoma; gastroesophageal junction adenocarcinoma; nanosomal docetaxel lipid suspension

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Mol Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: India Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google